Insert title here

HTML Full Text

Review Article


Year: 2025 |Volume: 6 | Issue: 08 |Pages: 55-65


Herbal Drug Development and Phytochemical Research in Ayurveda – A review article

About Author

Chaudhari V.1 , Paul R. 2

1PG scholar, Department of Dravyaguna, Amrita school of Ayurveda, Kollam, Kerala

2Professor Department of Dravyaguna, Amrita school of Ayurveda, Kollam, Kerala

Correspondence Address:

Dr. Vivek Y. Chaudhari PG scholar, Department of Dravyaguna, Amrita school of Ayurveda, Kollam, Kerala Email: Vivekchaudhari433@gmail.com

Date of Acceptance: 2025-08-03

Date of Publication:2025-09-02

Article-ID:IJIM_417_09_25 http://ijim.co.in

Source of Support: Nil

Conflict of Interest: Non declared

How To Cite This Article: Chaudhari V., Paul R. Herbal Drug Development and Phytochemical Research in Ayurveda – A review article. Int J Ind Med 2025;6(08):55-65 DOI: http://doi.org/10.55552/IJIM.2025.60811

Abstract

Introduction: People around the world are buying more herbal medicines because they think they are safe, cheap, and work. India has a unique place in the herbal pharmaceutical industry because of its long history of practices like Ayurveda. But the acceptance and commercialisation of herbal products in modern times are held back by problems with standardisation, validation, and the regulatory infrastructure. Method: We used a descriptive review method to look at data from government agencies (like AYUSH and NMPB), WHO reports, and academic articles. Regulatory acts, cultivation practices, pharmacopoeia standards, and market trends in the herbal sector were some of the main areas of focus. Results: India has put in place a number of programs and rules, such as the Drugs and Cosmetics Act (1940), to promote herbal medicine. Even so, there are still problems like inconsistent quality control, not enough clinical validation, and fragmented supply chains persist. India's export potential remains underutilized compared to countries like China due to weaker research and global compliance. Discussion: To capitalize on its herbal wealth, India must invest in scientific validation, regulatory harmonization with global standards (e.g., WHO-GMP), and strengthen its supply and training infrastructure. Strategic reforms can position India as a global leader in herbal drug development.

Keywords: Herbal medicine, Drug standardization, Herbal pharmacopoeia, WHO-GMP, Indian medicinal plants, Natural drug development

Introduction

Introduction and background

Ayurveda, a traditional system of medicine that originated in ancient India, places a strong emphasis on herbal formulations and phytochemicals for therapeutic purposes [10]. The Indian Materia Medica, a significant text in Ayurveda, comprises approximately 2000 drugs of natural origin, primarily derived from various traditional systems and folklore practices [2]. This herbal drug development often adopts a reverse pharmacology approach, shifting from 'clinics-to-laboratories' rather than the conventional 'laboratory-to-clinics' model [4]. This method allows for the exploration of potential therapeutic targets associated with Ayurvedic herbs and herbal products, highlighting the significant therapeutic activities of several lead molecules developed from these sources [3][1]. Ayurvedic formulations typically consist of multiple medicinal herbs, sometimes incorporating minerals and metals, which are believed to enhance the therapeutic effects through synergistic actions [9][7]. However, challenges remain in the promotion and development of these herbal products, including the need for thorough chemo-profiling, safety evaluations, and quality control measures [5]. While laboratory experiments indicate that some Ayurvedic herbs may hold promise as effective treatments, there is currently a lack of evidence supporting their efficacy in clinical settings [6]. The integration of artificial intelligence in Ayurvedic herbology offers a promising avenue for accelerating drug discovery, identifying novel herbal combinations, and predicting therapeutic outcomes [8]. Phytochemical studies consistently investigate the chemical compounds present in these herbs, further informing the development of Ayurvedic therapies [11]. Overall, Ayurveda's focus on complex herbal compounds represents a unique approach to drug development, distinguishing it from conventional medicine practices

Methods

This study employs a descriptive and analytical review approach based on secondary data sources including:

  • Reports from the World Health Organization (WHO) and Indian government bodies like AYUSH and NMPB (National Medicinal Plants Board).
  • Published literature on herbal drug development, regulatory procedures, and pharmacopeial standards.
  • Analysis of herbal raw material supply chains, regulatory acts (e.g., Drugs and Cosmetics Act, 1940), and global market reports.

The evaluation also includes data on cultivation practices, quality control mechanisms, and marketing strategies adopted by Indian and international herbal product manufacturers.

Results

Importance of Phytochemical Research in Ayurveda

Phytochemical research plays a crucial role in Ayurveda, as it involves the investigation of the chemical compounds present in plants that are fundamental to traditional medicine practices. These studies focus on isolating, characterizing, and evaluating the various phytoconstituents found in herbal extracts, which helps in understanding their biological activities and potential health benefits [13]. By exploring the therapeutic properties of these plant-derived chemicals, researchers aim to identify applications in medicine, pharmaceuticals, and overall health and wellness [13]. This scientific approach not only validates traditional Ayurvedic knowledge but also enhances the development of herbal drugs that can effectively promote health and treat diseases, aligning with contemporary health sciences [13].

Integration of Traditional and Modern Practices

Integrating traditional Ayurvedic principles with modern clinical practices can enhance patient care by offering a more holistic approach to health management. This integration involves several strategies, including promoting rigorous research and developing stringent standards for Ayurvedic practices and products [14][15]. Moreover, incorporating Ayurveda into medical school curricula and conducting workshops can help increase awareness and understanding of these traditional practices among healthcare professionals [16][17]. The collaboration between Ayurveda and modern medicine aims to provide personalized and effective healthcare solutions while respecting traditional practices [18][19]. However, this integration faces challenges such as the lack of uniform global standards for Ayurvedic products, which complicates regulatory approvals and quality assurance [21][22][24]. Additionally, issues such as a lack of awareness, misconceptions, and competition from modern medicine pose hurdles to the broader acceptance and application of Ayurvedic practices [23]. To overcome these challenges, advancements such as personalized medicine and digital health technologies are being incorporated into Ayurvedic practices, trans forming them to better align with contemporary medical standards [20]. Chemo profiling, which involves analysing the chemical constituents of herbal extracts, plays a critical role in assessing product quality and efficacy, thereby facilitating the integration of Ayurvedic formulations within modern healthcare frameworks [25][27]. High-resolution technologies like LC-MS/MS and NMR are increasingly employed to simplify metabolite profiling of plants used in Ayurveda [26]. Ultimately, the successful integration of Ayurvedic and modern medical practices hinges on a balanced approach that emphasizes both scientific validation and respect for traditional knowledge [18].

Regulatory Challenges

Key Regulatory Challenges for Ayurvedic Herbal Products

Ayurvedic herbal products face several regulatory challenges that hinder their approval in various markets. One significant issue is the absence of globally accepted certification mechanisms, which complicates the standardization of products and ensures their safety and efficacy [34][39].  

Furthermore, the lack of uniform global standards creates difficulties for manufacturers in meeting regulatory requirements, leading to inconsistencies in product quality [33][39]. The Ayurvedic industry also grapples with the scarcity of quality-certified herbal raw materials, which is crucial for maintaining the integrity of Ayurvedic formulations [35]. This supply issue, combined with lengthy approval processes for regulatory certifications, can delay product launches and limit market accessibility [39]. Additionally, there are concerns related to claim substantiation and product categorization, which further complicate the regulatory landscape for Ayurvedic products [38]. Moreover, the existing regulatory framework, such as the Drugs and Cosmetics Act of 1940, does not require comprehensive safety and efficacy studies for marketing approval of Ayurvedic products, potentially allowing subpar products to enter the market [37][40]. This lack of stringent oversight can result in trust issues among consumers, as they may question the reliability of Ayurvedic claims compared to modern medicine and supplements [36][38]. To address these challenges, strategies such as promoting rigorous research, developing stringent standards for Ayurvedic practices, and implementing regulatory reforms have been proposed. Incorporating Ayurveda into the curricula of medical schools and conducting awareness workshops could also enhance understanding and acceptance of Ayurvedic products within mainstream healthcare [29][30][31][32].

Role of International Harmonization of Regulatory Standards

International harmonization of regulatory standards plays a critical role in the ap approval process of Ayurvedic herbal products, significantly affecting their acceptance in global markets. The lack of harmonization in regulatory requirements for herbal products across different countries has been identified as a barrier to effective regulation, impacting the quality and availability of these products internationally [58][66]. Efforts by organizations such as the World Health Organization (WHO) aim to foster the convergence of pharmacopeial standards, which can enhance the accessibility and affordability of Ayurvedic products [59]. Regulatory authorities, including the FDA and EMA, are working towards aligning technical requirements to ensure quality, safety, and efficacy standards are met for herbal products [63][64]. Furthermore, collaboration among regulatory agencies and international organizations is crucial in establishing standardized quality and safety benchmarks for herbal medicines [60][61].Despite these efforts, challenges remain, including insufficient research on herbal medicines and a general lack of robust regulatory mechanisms [69]. The goal of regulatory harmonization is to address these issues, facilitating the smooth development and marketing of Ayurvedic products globally [64]. In India, the AYUSH regulatory framework governs the approval of classical herbal medicines, contrasting with the less defined status of such products under U.S. law [70][71]. This discrepancy underscores the need for international consensus on regulatory standards to improve the global acceptance of Ayurvedic formulations [65][66]

Challenges in Research

The isolation and characterization of bioactive compounds from Ayurvedic plants face several challenges. One of the primary difficulties is the extraction process, which is crucial for obtaining the desired chemical components from the plant material.[46] [ 50]. Different phytochemicals exhibit varying solubility, which complicates the extraction; for instance, while some phenolic acids are water-soluble and easily extracted, others are insoluble secondary metabolites that present greater challenges.[48] To address these challenges, researchers often employ a range of analytical techniques. Common methods include UV-Visible spectroscopy, infrared spectroscopy (IR), mass spectrometry, and various chromatographic techniques such as high-performance liquid chromatography (HPLC) and thin-layer chromatography (TLC).[42] [43][45] These techniques facilitate both qualitative and quantitative analyses of the phytochemicals present.[45] Additionally, a multiparametric protocol comprising multiple biochemical assays has been developed to effectively quantify major categories of phytochemicals, thereby enhancing the understanding of their properties.[44] However, beyond technical hurdles, regulatory issues also complicate the research landscape. There is a notable lack of harmonization in the regulatory requirements for herbal products across different countries, which can affect the consistency and availability of Ayurvedic medicines.[52][54] Regulatory agencies like the FDA and EMA impose strict standards for quality, safety, and efficacy of herbal products, adding another layer of complexity to the development process.[53] Researchers must navigate these regulatory landscapes to ensure their findings and products comply with international standards, further complicating the isolation and characterization of bioactive compounds from Ayurvedic plants.[54][55]

Effective Ayurvedic Formulations

Research has shown that various Ayurvedic herbal formulations possess significant bioactive phytochemical compounds that contribute to their therapeutic effects. These formulations are often analysed using advanced spectroscopic techniques, such as UV-Visible, IR, NMR, and mass spectrometry, which help in determining their chemical structures and validating their efficacy [74][75]. A systematic review highlighted the importance of bioactive compounds in Ayurvedic medicines, emphasizing the therapeutic uses and advanced extraction methods for six prominent formulations [ 78]. Clinical studies have provided insights into the effectiveness of specific polyherbal formulations, revealing that they are enriched with pharmaceutical values and beneficial therapeutic properties [73]. The meticulous approach to extraction, isolation, and characterization of these compounds has shed light on the rich biodiversity of medicinal plants used in Ayurveda [76]. Despite the promising findings, there is a noted lack of harmonization in the regulatory requirements for herbal products globally, which presents challenges for their availability and compliance [79][80]. Nonetheless, ongoing research continues to uncover the potential of these formulations in various health contexts, reinforcing the relevance of Ayurvedic practices in contemporary herbal drug development [81].

Discussion

The development of herbal medicine in India stands at a critical juncture where traditional knowledge and modern science must intersect. Despite the rich heritage of Ayurveda and the vast biodiversity of medicinal plants, India faces several systemic challenges that hinder the global competitiveness of its herbal products. Key barriers include lack of standardization, inconsistent quality of raw materials, limited clinical trials, and inadequate funding for R&D. Moreover, regulatory mechanisms, although present through acts like the Drugs and Cosmetics Act (1940), are not always aligned with global standards such as WHO-GMP and GLP, which restricts export potential and international recognition. Government initiatives like the Ministry of AYUSH, National AYUSH Mission, and support from the National Medicinal Plants Board (NMPB) have laid the groundwork for policy and infrastructure. However, successful implementation requires stronger interdisciplinary collaboration, better training, and investment in innovation, particularly in toxicity profiling, pharmacokinetics, and supply chain transparency. In conclusion, while India has the cultural and natural resources to dominate the herbal market, it needs to overcome scientific, regulatory, and infrastructural shortcomings. A strategic integration of traditional wisdom with modern scientific rigor can propel India to the forefront of global herbal drug development.

Conclusion

India’s herbal medicine sector holds immense potential, rooted in Ayurveda and rich biodiversity, yet its global impact is limited by gaps in standardization, quality control, research validation, and regulatory alignment. While initiatives by the Ministry of AYUSH and allied bodies have created a supportive framework, real progress depends on stronger interdisciplinary collaboration, modern scientific validation, and transparent supply chains. By integrating traditional wisdom with global research standards and innovation, India can transform its heritage into internationally recognized, competitive, and trusted herbal products, thereby establishing itself as a leader in the global herbal medicine market.

References

  1. Balachandran P, Govindarajan R. Ayurvedic drug discovery. Expert Opin Drug Discov. 2007 Dec;2(12):1631-52. doi: 10.1517/17460441.2.12.1631. PMID: 23488906.
  2. Pulok K. Mukherjee, Atul Wahile,Integrated approaches towards drug development from Ayurveda and other Indian system of medicines,Journal of Ethnopharmacology,Volume 103, Issue 1,2006,Pages 25-35,ISSN 0378-8741.
  3. Mukherjee PK, Harwansh RK, Bahadur S, Banerjee S, Kar A, Chanda J, Biswas S, Ahmmed SM, Katiyar CK. Development of Ayurveda - Tradition to trend. J Ethnopharmacol. 2017 Feb 2;197:10-24. doi: 10.1016/j.jep.2016.09.024. Epub 2016 Sep 12. PMID: 27633405.
  4. Patwardhan, B. (2023). Where lies the future of Ayurveda-inspired drug discovery? Expert Opinion on Drug Discovery18(9), 947–949. https://doi.org/10.1080/17460441.2023.2228201
  5.  Bilia AR, Mukherjee PK, Andrade-Cetto A, Katiyar CK, Bachar SC, Matsabisa MG and Mandal SC (2022) Editorial: Drug development of herbal medicines: Regulatory perspectives. Front. Pharmacol. 13:989934. doi: 10.3389/fphar.2022.989934
  6. Ayurveda - Wikipedia
  7. acf224c1e044f2d7e6a097eac566af59.pdf
  8. Balachandran, Premalatha & Govindarajan, Rajgopal. (2007). Ayurvedic drug discovery. Expert opinion on drug discovery. 2. 1631-1652. 10.1517/17460441.2.12.1631.
  9. Sulaiman C? T?, Advaya G? R?, Shafna T?, Ramesh P? R?, Mahesh K?, Praveen M?, Anandan E? M?, Indira Balachandran, Phytochemistry and bioactives of ingredient plants of a Polyherbal formulation, Next Research, Volume 1, Issue 2,2024,100078,ISSN 3050-4759
  10. International Journal of Ayurveda Research 5(1):p 11-16, Jan–Mar 2024. | DOI: 10.4103/ijar.ijar_33_24
  11. https://www.wisdomlib.org/concept/phytochemical-studies
  12. Ayurveda - Wikipedia
  13. Phytochemical studies: Significance and symbolism
  14. Verma, S.K., Pandey, M., Sharma, A. et al. Exploring Ayurveda: principles and their application in modern medicine. Bull Natl Res Cent 48, 77 (2024). https://doi.org/10.1186/s42269-024-01231-0
  15. Gupta, Rajeev. (2024). Integrating Ayurveda with Modern Medicine for Enhanced Patient Care: Analysis of Realities. The Physician. 9. 1-6. 10.38192/1.9.1.3.
  16. Gupta, R. (2024) Integrating Ayurveda with modern medicine for enhanced patient care- analysis of realities. The Physician vol 9; Issue 1:1-6 DOI 10.38192/1.9.1.3
  17. Journal of Primary Care Specialties 5(1):p 11-15, Jan–Apr 2024. | DOI: 10.4103/jopcs.jopcs_36_23
  18. Indian Journal of Ayurveda and Integrative Medicine KLEU 5(2):p 51-53, Jul–Dec 2024. | DOI: 10.4103/ijaim.ijaim_48_24
  19. Ilkogretim Online - Elementary Education Online, 2019; Vol 18 (Issue 4): pp. 2505-2512 http://ilkogretim-online.org doi: 10.17051/ilkonline.2019.641246
  20. https://doi.org/10.21760/jaims.10.1.ED
  21. Ayurvedic Products Market Trends and Future Opportunities :CMR
  22. Sabharwal P, Singh I. Anticipating tomorrow: Future trends and predictions in Ayurveda entrepreneurship. Future Health. 2024;2:127-32. doi: 10.25259/FH_41_2024
  23. Challenges in Marketing Ayurvedic Products and How to Overcome Them
  24. Ayurvedic Cosmetics Regulation in India: Why Reform Matters
  25. Pimpalshende, Pankaj & Kosalge, S. & JADHAVE, PRAMOD. (2024). CHEMOPROFILING: RECENT AND FUTURE PROSPECTUS. International Journal of All Research Education & Scientific Methods. 12. 359-364.
  26. Ritu Tiwari, Smita Mishra, Aishwarya Chauhan, Poornima Gulati, Mahaveer Dhobi,The Dawn till Dusk of phytopharmaceuticals,Saudi Pharmaceutical Journal,Volume 32, Issue 11,2024,102185,ISSN 1319-0164,
  27. Mukherjee PK, Harwansh RK, Bahadur S, Banerjee S, Kar A, Chanda J, Biswas S, Ahmmed SM, Katiyar CK. Development of Ayurveda - Tradition to trend. J Ethnopharmacol. 2017 Feb 2;197:10-24. doi: 10.1016/j.jep.2016.09.024. Epub 2016 Sep 12. PMID: 27633405.
  28. Patwardhan B. Bridging Ayurveda with evidence-based scientific approaches in medicine. EPMA J. 2014 Nov 1;5(1):19. doi: 10.1186/1878-5085-5-19. PMID: 25395997; PMCID: PMC4230501.
  29. Gupta, Rajeev. (2024). Integrating Ayurveda with Modern Medicine for Enhanced Patient Care: Analysis of Realities. The Physician. 9. 1-6. 10.38192/1.9.1.3.
  30. Gupta, R. (2024) Integrating Ayurveda with modern medicine for enhanced patient care- analysis of realities. The Physician vol 9; Issue 1:1-6 DOI 10.38192/1.9.1.3
  31. Journal of Primary Care Specialties 5(1):p 11-15, Jan–Apr 2024. | DOI: 10.4103/jopcs.jopcs_36_23
  32. Hegde, Harsha; Barvaliya, Manish1; Roy, Subarna2. Integrating Ayurveda and Conventional Medicine: A Bridge to Be Built for Holistic Health. Indian Journal of Ayurveda and Integrative Medicine KLEU 5(2):p 51-53, Jul–Dec 2024. | DOI: 10.4103/ijaim.ijaim_48_24
  33. https://www.cognitivemarketresearch.com/articles/ayurvedic-products-market-trends-and-future-opportunities
  34.  Sabharwal P, Singh I. Anticipating tomorrow: Future trends and predictions in Ayurveda entrepreneurship. Future Health. 2024;2:127-32. doi: 10.25259/FH_41_2024
  35. Katiyar, Chandra Kant; Dubey, Sunil Kumar1. Opportunities and challenges for Ayurvedic industry. International Journal of Ayurveda Research 4(3):p 123-131, Jul–Sep 2023. | DOI: 10.4103/ijar.ijar_114_23
  36. https://www.linkedin.com/pulse/challenges-marketing-ayurvedic-products-how-overcome-them-sn-byb5c
  37. Sahoo N, Manchikanti P. Herbal drug regulation and commercialization: an Indian industry perspective. J Altern Complement Med. 2013 Dec;19(12):957-63. doi: 10.1089/acm.2012.0275. Epub 2013 Jul 5. PMID: 23829812; PMCID: PMC3868382.
  38. https://www.gcrs.co.uk/fr/ayurvedic-cosmetics-regulation-india/
  39. https://www.linkedin.com/posts/giosunhealthcare_navigating-regulatory-hurdles-in-ayurveda-activity-7309806767918432256-XJ9P
  40. Bilia AR, Mukherjee PK, Andrade-Cetto A, Katiyar CK, Bachar SC, Matsabisa MG and Mandal SC (2022) Editorial: Drug development of herbal medicines: Regulatory perspectives. Front. Pharmacol. 13:989934. doi: 10.3389/fphar.2022.989934
  41. Balekundri, A., Mannur, V. Quality control of the traditional herbs and herbal products: a review. Futur J Pharm Sci 6, 67 (2020). https://doi.org/10.1186/s43094-020-00091-5
  42. https://www.wisdomlib.org/health-sciences/journal/world-journal-of-pharmaceutical-research/d/doc1382982.html
  43. Muhammad, Murad & Begum, Sani & Ditta, Allah & Liu, Yong-Hong & Li, Li & Li, Wen-Jun. (2024). Metabolites Treasure from Endophytes: Advances, Applications and Technological Challenges. 10.1007/978-3-031-71487-0_8.
  44. Michalaki, A., & Grintzalis, K. (2023). A Multiparametric Protocol for the Detailed Phytochemical and Antioxidant Characterisation of Plant Extracts. Methods and Protocols6(2), 40. https://doi.org/10.3390/mps6020040
  45. Arora, Charu, Bharti, Dipti, Kishore Tiwari, Brij, Kumar, Ashish, Kumar Verma, Dakeshwar and Singh, Bhupender. "Chapter 6 Characterization techniques used for the analysis of phytochemical constituents". Phytochemicals in Medicinal Plants: Biodiversity, Bioactivity and Drug Discovery, edited by Charu Arora, Dakeshwar Kumar Verma, Jeenat Aslam and Pramod Kumar Mahish, Berlin, Boston: De Gruyter, 2023, pp. 131-152.
  46. Sasidharan S, Chen Y, Saravanan D, Sundram KM, Yoga Latha L. Extraction, isolation and characterization of bioactive compounds from plants' extracts. Afr J Tradit Complement Altern Med. 2011;8(1):1-10. Epub 2010 Oct 2. PMID: 22238476; PMCID: PMC3218439.
  47. El-Saadony MT, Saad AM, Mohammed DM, Korma SA, Alshahrani MY, Ahmed AE, Ibrahim EH, Salem HM, Alkafaas SS, Saif AM, Elkafas SS, Fahmy MA, Abd El-Mageed TA, Abady MM, Assal HY, El-Tarabily MK, Mathew BT, AbuQamar SF, El-Tarabily KA and Ibrahim SA (2025) Medicinal plants: bioactive compounds, biological activities, combating multidrug-resistant microorganisms, and human health benefits - a comprehensive review. Front. Immunol. 16:1491777. doi: 10.3389/fimmu.2025.1491777
  48. Rakha A, Shehzad A and Khan K (2024) Editorial: Plant bioactives: challenges of extraction and processing. Front. Nutr. 11:1357925. doi: 10.3389/fnut.2024.1357925
  49. Olaniyan, M.F., Olaniyi, O.D., Odegbemi, F. et al. Isolation and purification techniques for bioactive compounds from Nigerian medicinal plants and their therapeutic applications. Discov. Chem. 2, 13 (2025). https://doi.org/10.1007/s44371-025-00098-y
  50. Molecules | Special Issue : Bioactive Compounds from Plants: Extraction and Characterization
  51. Fotsing Yannick Stéphane, F., Kezetas Jean Jules, B., El-Saber Batiha, G., Ali, I., & Ndjakou Bruno, L. (2022). Extraction of Bioactive Compounds from Medicinal Plants and Herbs. IntechOpen. doi: 10.5772/intechopen.98602
  52. Sharma S. Current status of herbal product: Regulatory overview. J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):293-6. doi: 10.4103/0975-7406.168030. PMID: 26681886; PMCID: PMC4678984.
  53. https://www.ijpca.org/html-article/22977
  54. Evolution of Regulatory requirements for herbal medicines
  55. Sharma S. Current status of herbal product: Regulatory overview. J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):293-6. doi: 10.4103/0975-7406.168030. PMID: 26681886; PMCID: PMC4678984.
  56. Analytical techniques used in phytochemistry- a comprehensive review
  57. Arora, Charu, Bharti, Dipti, Kishore Tiwari, Brij, Kumar, Ashish, Kumar Verma, Dakeshwar and Singh, Bhupender. "Chapter 6 Characterization techniques used for the analysis of phytochemical constituents". Phytochemicals in Medicinal Plants: Biodiversity, Bioactivity and Drug Discovery, edited by Charu Arora, Dakeshwar Kumar Verma, Jeenat Aslam and Pramod Kumar Mahish, Berlin, Boston: De Gruyter, 2023, pp. 131-152.
  58. Sharma S. Current status of herbal product: Regulatory overview. J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):293-6. doi: 10.4103/0975-7406.168030. PMID: 26681886; PMCID: PMC4678984.
  59. Towards global harmonization: WHO’s International Herbal Pharmacopoeia Meeting in Hong Kong SAR
  60. Mohan, Rohit & Singh, Virendra & Yadav, Pankaj & Kumar, Yogesh & Singh, Mangla & Priyansha, & Singh, Laliteshwer & Kumar, Lalit & Kumar, Jayendra. (2025). Regulatory aspects of ayurvedic medicines around the globe: An Updated review. European Journal of Molecular & Clinical Medicine. 9. 9093-9115.
  61. https://yemenjmed.com/admin/uploads/1/10_pdf.pdf
  62. Charde, Vaibhav Anandrao1,; Dane, Ganesh1; Kaur, Harmeet2; Jagtap, Chandrashekhar Yuvaraj1; Kumar, Vijay1; Sarkar, Biresh Kumar3; Babu, G.1; Sharma, Bhagwan Sahai4. An overview of current manufacturing guidelines for Ayurveda formulations. Journal of Drug Research in Ayurvedic Sciences 6(3):p 122-127, Jul–Sep 2021. | DOI: 10.4103/jdras.jdras_1_21
  63. WHO guidelines for quality control of herbal medicines: From cultivation to consumption - IJPCA
  64. https://www.fda.gov/drugs/cder-international-program/international-regulatory-harmonization
  65. https://wjpr.s3.ap-south-1.amazonaws.com/article_issue/f8b0b13f4896de383eb4979f213de3b6.pdf
  66. Sharma S. Current status of herbal product: Regulatory overview. J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):293-6. doi: 10.4103/0975-7406.168030. PMID: 26681886; PMCID: PMC4678984.
  67. Sahoo N, Manchikanti P. Herbal drug regulation and commercialization: an Indian industry perspective. J Altern Complement Med. 2013 Dec;19(12):957-63. doi: 10.1089/acm.2012.0275. Epub 2013 Jul 5. PMID: 23829812; PMCID: PMC3868382.
  68. Chevon R. Jordan, Calin M. Harris, Miranda I. Miranda, Diane Y. Kim, Rosalee S. Hellberg,Labeling compliance and online claims for Ayurvedic herbal supplements on the U.S. market associated with the purported treatment of COVID-19,Food Control,Volume 148,2023,109673,ISSN 0956-7135
  69. Dubale S, Usure RE, Mekasha YT, Hasen G, Hafiz F, Kebebe D and Suleman S (2025) Traditional herbal medicine legislative and regulatory framework: a cross-sectional quantitative study and archival review perspectives. Front. Pharmacol. 16:1475297. doi: 10.3389/fphar.2025.1475297
  70. Jadhav, R., Das, J., Rajyaguru, S. et al. Regulations, current development, and future prospects of phytopharmaceuticals, a new class of herbal medicines in India. Discov. Pharm. Sci. 1, 6 (2025). https://doi.org/10.1007/s44395-025-00006-4
  71. FDA India Office Addresses Herbal and Ayurvedic Products | FDA
  72. Ilie EI, Popescu L, Lu?? EA, Bi?? A, Corbu AR, Mihai DP, Pogan AC, Balaci TD, Minc? A, Du?u LE, Olaru OT, Boscencu R, Gîrd CE. Phytochemical Characterization and Antioxidant Activity Evaluation for Some Plant Extracts in Conjunction with Pharmacological Mechanism Prediction: Insights into Potential Therapeutic Applications in Dyslipidemia and Obesity. Biomedicines. 2024 Jun 27;12(7):1431. doi: 10.3390/biomedicines12071431. PMID: 39062004; PMCID: PMC11274650.
  73. ACS Omega 2022, 7, 37, 33067–33078
  74. Arora, Charu & Bharti, Dipti & Tiwari, Brij & Kumar, Ashish & Verma, Dakeshwar & Singh, Bhupender. (2023). Chapter 6 Characterization techniques used for the analysis of phytochemical constituents. 10.1515/9783110791891-006.
  75. Arora, Charu, Bharti, Dipti, Kishore Tiwari, Brij, Kumar, Ashish, Kumar Verma, Dakeshwar and Singh, Bhupender. "Chapter 6 Characterization techniques used for the analysis of phytochemical constituents". Phytochemicals in Medicinal Plants: Biodiversity, Bioactivity and Drug Discovery, edited by Charu Arora, Dakeshwar Kumar Verma, Jeenat Aslam and Pramod Kumar Mahish, Berlin, Boston: De Gruyter, 2023, pp. 131-152.
  76. Fonmboh, D. J., Abah, E. R., Fokunang, T. E., Herve, B., Teke, G. N., Rose, N. M., Borgia, N. N., Fokunang, L. B., Andrew, B. N., Kaba, N., Bathelemy, N., & Ntungwen, F. C. (2020). An Overview of Methods of Extraction, Isolation and Characterization of Natural Medicinal Plant Products in Improved Traditional Medicine Research. Asian Journal of Research in Medical and Pharmaceutical Sciences9(2), 31–57.
  77. dos Santos, M.S.N., Wancura, J.H.C., Oro, C.E.D., Dallago, R.M., Tres, M.V. (2022). Opportunities and Challenges of Plant Bioactive Compounds for Food and Agricultural-Related Areas. Phyton-International Journal of Experimental Botany91(6), 1105–1127. https://doi.org/10.32604/phyton.2022.020913
  78. Olaniyan, M.F., Olaniyi, O.D., Odegbemi, F. et al. Isolation and purification techniques for bioactive compounds from Nigerian medicinal plants and their therapeutic applications. Discov. Chem. 2, 13 (2025). https://doi.org/10.1007/s44371-025-00098-y
  79. Sharma S. Current status of herbal product: Regulatory overview. J Pharm Bioallied Sci. 2015 Oct-Dec;7(4):293-6. doi: 10.4103/0975-7406.168030. PMID: 26681886; PMCID: PMC4678984.
  80. Chevon R. Jordan, Calin M. Harris, Miranda I. Miranda, Diane Y. Kim, Rosalee S. Hellberg, Labeling compliance and online claims for Ayurvedic herbal supplements on the U.S. market associated with the purported treatment of COVID-19,Food Control, Volume 148,2023, 109673, ISSN 0956-7135,

CGMP Compliance and Herbal Products: A Guide to Regulatory Requirements - MUIH

 

 

PDF
Insert title here